The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

I-131! Getchyer Rrrred Hot I-131 Here! Health Canada Approves Alternate Source for Thryoid Cancer Treatment

683px-Schematicky_atomDraximage has been approved by Health Canada to supply I-131 from South Africa’s Safari reactor to treat Canadian thyroid cancer patients. As the Health Canada press release points out, “[p]roduction of I-131 in Canada was interrupted by the unplanned shutdown of the Chalk River National Research Universal reactor (NRU) in May 2009.” Draximage is a division of DRAXIS Specialty Pharmaceuticals, which was bought by Jubliant Organosys in May 2008.

Update: Good thing too, because the Chalk River reactor may be out of commission through the Fall or even into 2010.

Bookmark and Share

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s


Get every new post delivered to your Inbox.

Join 128 other followers